QT Imaging Holdings, Inc. (NASDAQ:QTI – Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 15th, there was short interest totaling 495,661 shares, a growth of 73.4% from the April 30th total of 285,907 shares. Approximately 5.8% of the shares of the company are sold short. Based on an average daily volume of 100,466 shares, the short-interest ratio is currently 4.9 days.
QT Imaging Price Performance
QTI traded down $0.23 on Tuesday, hitting $4.47. 34,098 shares of the company’s stock traded hands, compared to its average volume of 80,404. The company’s 50 day simple moving average is $6.32 and its 200-day simple moving average is $6.06. The firm has a market cap of $53.78 million, a price-to-earnings ratio of -3.92 and a beta of 0.01. QT Imaging has a one year low of $0.72 and a one year high of $8.50. The company has a current ratio of 2.49, a quick ratio of 1.69 and a debt-to-equity ratio of 1.38.
QT Imaging (NASDAQ:QTI – Get Free Report) last issued its earnings results on Wednesday, May 13th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.11). QT Imaging had a negative net margin of 58.93% and a negative return on equity of 4,220.38%. The business had revenue of $6.53 million for the quarter, compared to the consensus estimate of $6.45 million. As a group, research analysts anticipate that QT Imaging will post -0.59 EPS for the current year.
Wall Street Analysts Forecast Growth
Read Our Latest Report on QT Imaging
About QT Imaging
QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.
QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.
Further Reading
- Five stocks we like better than QT Imaging
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
